Collizns and KIMEDI Jointly Develop Blockchain-Based Reward System

Blockchain specialist company Collizns announced on the 20th that it has signed a strategic business agreement (MOU) with the medical marketing platform KIMEDI to embark on a joint project to enhance the reward system using blockchain technology.

Collizns is currently developing a foreign patient attraction platform 'Medi7' and is also stably operating an MPC-based virtual asset (cryptocurrency) wallet 'Talken'.

Through this agreement, Collizns plans to more precisely measure the contributions of doctor members active within the KIMEDI platform and provide appropriate rewards. The aim is to increase not only simple community rewards but also the revisit rate of the medical community and the sustainability of the platform ecosystem.

KIMEDI has been operating its own point system to reward doctor members for their activities within the platform. Through the introduction of blockchain technology, the two companies plan to further enhance the transparency, scalability, and flexibility of the points. They also plan to expand the scope of point usage and exchange value in the future.

Yunhee Kim, CEO of Collizns, said, "We aim to provide substantial user benefits by integrating Collizns' blockchain technology into KIMEDI's medical platform," adding, "This agreement will be a model case for enhancing the transparency and scalability of medical services."

Myeongjin Kim, CEO of KIMEDI, stated, "The key to platform growth lies in the active participation and contribution of doctor members," and expressed expectations for increased retention and community activation by establishing a sophisticated and meaningful reward structure.